Existing Drugs Show Promise in Eliminating Hidden Breast Cancer Cells, Preventing Recurrence
Philadelphia, PA – A groundbreaking clinical study from the University of Pennsylvania has revealed that commonly used medications, originally prescribed for other conditions, can effectively eliminate dormant tumor cells responsible for breast cancer recurrence. This innovative approach offers a potential new avenue for treatment and considerably reduces the risk of the disease returning, providing renewed hope for survivors.
Despite advancements in breast cancer detection and treatment leading to increased survival rates, recurrence remains a devastating reality for approximately 30% of patients. When breast cancer returns after initial therapy, it often becomes incurable, leaving patients facing indefinite, palliative treatment aimed at controlling – but not eliminating – the disease. The timeframe for recurrence varies;
